drugset / Trial / NCT00197171

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

NCT00197171

Phase 3 Completed 143 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the persistence of immune response 5 years and 6 years after the first vaccine dose.

Timeline

Start
2003-09
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TWINRIX™ ADULT Vaccine